SeaStar Medical logo

SeaStar Medical

ICU | NASDAQ
Chart Builder DCF Calculator
$3.47
-$0.11 (-3.07%)
Sep 22, 2026, 11:31 AM ET · Market open

Market Data

Market Cap
$10.16M
Enterprise Value
$3.2M
Beta
-1.03
Average Volume
83.45K
Shares Outstanding (Diluted)
4.08M
Shares Change YoY
133.31%
Institutional Ownership
3.22%
Exchange
NASDAQ
ISIN
US81256L3024

Price Performance

Price Change 1M
7.2%
Price Change 3M
3.2%
Price Change 6M
57.0%
Price Change YTD
36.1%
Price Change 1Y
-64.2%
Price Change 3Y
-92.1%
Price Change 5Y
-99.9%
1M CAGR (ann.)
9.2%
1Y CAGR (ann.)
-60.2%
5Y CAGR (ann.)
N/A
All-Time CAGR
-80.8%

Valuation

PE Ratio
-0.92
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.02
PS Ratio
5.93
Forward PS
3.40
PB Ratio
2.36
P/FCF Ratio
-0.74
P/Adj. FCF Ratio
-0.72
P/OCF Ratio
-1.07
EV/Sales
1.87
EV/EBIT
-0.23
EV/EBITDA
-0.23
EV/FCF
-0.23
Earnings Yield
-109.2%
FCF Yield
-134.8%
Adj. FCF Yield
-138.2%

Financial Health

Net Cash
$6.96M
Total Debt
$0
Cash & Short-Term Investments
$6.96M
Total Assets
$8.65M
Current Ratio
1.89
Quick Ratio
1.87
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-518.11
Altman Z-Score
-28.82
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
92.6%
Operating Profit Margin
-816.6%
EBITDA Margin
-797.5%
Net Profit Margin
-795.5%
FCF Margin
-799.4%
Adj. FCF Margin
-819.9%
SBC / Revenue
20.6%
SBC Impact (per share)
-2.6%

Returns

Return on Assets
-157.6%
Return on Equity
-162.8%
Return on Invested Capital
-325.6%
Return on Capital Employed
-325.6%
Return on Tangible Assets
-157.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
103.7%
Revenue CAGR 5Y
84.5%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
128.2%
EPS CAGR 5Y
40.6%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-5.7%
FCF CAGR 5Y
-16.6%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.95
EPS Growth Est (next Q)
-26.9%
Revenue Est (next Q)
$500K
Revenue Growth Est (next Q)
173.2%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$8
Price Target Upside
123.5%

Cash Flow

Operating Cash Flow
$-13.69M
Free Cash Flow
$-13.69M
Adj. Free Cash Flow
$-14.05M
FCF Per Share
-$3.35
OCF Per Share
-$3.35
OCF/S Ratio
-799.4%

Income Statement

Revenue
$1.71M
Gross Profit
$1.59M
Operating Income
$-13.99M
EBITDA
$-13.66M
Net Income
$-13.63M
EPS (Diluted)
-$3.91
Revenue / Employee
$95.17K
Profit / Employee
$-757.06K
Employees
18

© 2026 bestshares.com. All rights reserved.